Forbes December 6, 2022
At Illumina’s Genomics Forum conference this fall, former President Obama spoke about how precision medicine has a “considerable role to play in making the health system more efficient and producing better outcomes,” but that it has not yet realized its full potential.
Indeed, precision medicine holds tremendous promise, but still has a long way to go, in particular with respect to efficiently connecting the dots between diagnostics and therapeutics during clinical development.
Clinical validity and utility
Precision medicine relies on the clinical validity of diagnostic tests, or the accurate identification of patients with certain biomarker alterations. Clinical validity is, however, a necessary and not a sufficient condition for successful implementation of personalized medicine. To achieve success, clinical utility is needed,...